Stem Cell Therapy Market Size Was Valued at USD 12.05 Billion in 2023, and is Projected to Reach USD 31.33 Billion by 2032, ...
The research highlights how evolution repurposes existing genetic tools, turning them into versatile drivers of innovation.
Harvard Medical School will accredit a new Continuing Education course on stem cell therapies developed by the International ...
An IBEC-led study has revealed how mesenchymal stem cells respond to the viscosity of their environment, a key aspect in ...
The Maryland Stem Cell Research Commission (MSCRC) announces the release of a Request for Applications (RFA) for the Maryland ...
StemCyte Inc., a wholly owned subsidiary of StemCyte International Ltd., announced today that the U.S. Food and Drug ...
A research team led by Marina Emborg, professor of medical physics in the UW–Madison School of Medicine and Public Health, ...
Cyclosporin H boosts a new lentivirus-delivered gene therapy with enhanced anti-sickling properties in blood stem cells from ...
The BLA approval is supported by data from the COBLT study, FDA dockets and public information, and from a RegeneCyte observational database.
MSCRF invites applications across seven key grant programs to propel innovation in regenerative medicine ...
MSCRF grants support both young and established scientists, companies and research organizations to accelerate and advance the commercialization of innovative stem cell technologies for positive ...